Limitations and niches of the active targeting approach for nanoparticle drug delivery

European Journal of Nanomedicine

Volumn 4, Issue 2-4, 2012, Pages 89-93

  Chen, Weihsu Claire ^a   Zhang, Andrew X ^a   Li, Shyh Dar ^a,b  

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Active targeting; Antibody; Immunoliposomes; Nanoparticles; Targeting ligand

Indexed keywords

ACTIVE TARGETING; BIODISTRIBUTIONS; BLOOD CIRCULATION; IMMUNOGENICITY; IMMUNOLIPOSOMES; LYSOSOMAL DEGRADATION; TARGETING LIGANDS; TUMOR PENETRATION;

ANTIBODIES; CARDIOVASCULAR SYSTEM; DRUG DELIVERY; LIGANDS; TUMORS;

NANOPARTICLES;

DOXORUBICIN; FOLIC ACID; IMMUNOLIPOSOME; LIPOSOME; MONOCLONAL ANTIBODY; NANOPARTICLE;

CIRCULATION TIME; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; IMMUNOGENICITY; INTERNALIZATION; MONONUCLEAR PHAGOCYTE; NONHUMAN; PLASMA CLEARANCE; REVIEW; TARGET CELL; TUMOR INVASION; TUMOR VASCULARIZATION;

EID: 84882428508     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2012-0010     Document Type: Review

References (18)

1. Huang A, Huang L, Kennel SJ. Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting. J Biol Chem 1980;255:8015-8.
2. Cardoso MM, Peca IN, Roque AC. Antibody-conjugated nanoparticles for therapeutic applications. Curr Med Chem 2012; 19:3103-27.
3. Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 2008;5:496-504.
4. Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res [Research Support, N.I.H., Extramural] 2006;66:6732-40.
5. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. Impact of tumor-specific targeting on the biodistribution and effi cacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA. [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.] 2007;104:15549-54.
6. Li SD, Chen YC, Hackett MJ, Huang L. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther 2008; 16:163-9.
7. Harding JA, Engbers CM, Newman MS, Goldstein NI, Zalipsky S. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. Biochim Biophys Acta 1997;1327:181-92.
8. Cheng WW, Allen TM. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab'fragments and single chain Fv. J Control Release 2008;126:50-8.
9. Chen WC, Completo GC, Sigal DS, Crocker PR, Saven A, Paulson JC. In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood 2010;115:4778-86.
10. Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S. In vivo fate of folate-targeted polyethyleneglycol liposomes in tumor-bearing mice. Clin Cancer Res 2003;9:6551-9.
11. Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S. Tumor cell targeting of liposome-entrapped drugs with phospholipidanchored folic acid-PEG conjugates. Adv Drug Deliv Rev 2004;56:1177-92.
12. McNeeley K, Annapragada A, Bellamkonda R. Decreased circulation time offsets increased effi cacy of PEGylated nanocarriers targeting folate receptors of glioma. Nanotechnology. 2007;18:385101.
13. Lee H, Fonge H, Hoang B, Reilly RM, Allen C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol Pharm 2010;7:1195-208.
14. Collins D, Huang L. Cytotoxicity of diphtheria toxin A fragment to toxin-resistant murine cells delivered by pH-sensitive immunoliposomes. Cancer Res 1987;47:735-9.
15. Li SD, Huang L. Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting. J Control Release 2010;145:178-81.
16. Magnussen A, Kasman IM, Norberg S, Baluk P, Murray R, McDonald DM. Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels. Cancer Res 2005;65:2712-21.
17. Simberg D, Duza T, Park JH, Essler M, Pilch J, Zhang L, et al. Biomimetic amplifi cation of nanoparticle homing to tumors. Proc Natl Acad Sci USA 2007;104:932-6.
18. Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, et al. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 2007;25:327-37.